Evidence map›Paper›PMID 32066525›Full record

ArticleLancet (London, England)2020

Full spectrum of COVID-19 severity still being depicted.

Zhou Xu, Shu Li, Shen Tian, Hao Li, Ling-Quan Kong

3 registry-linked trialsAbstract readLetterComment
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04349592 nacompletednot on this map

Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

TypeinterventionalSponsorHamad Medical CorporationRan2020 to 2020Enrolled456ConditionsCovid19ArmsHydroxychloroquine, Azithromycin, Placebo Tablet, Placebo capsules
NCT04390269 unknown statusnot on this map

Various Molecular Markers With Predictive and Prognostic Significance in COVID-19 Outcome

TypeobservationalSponsorMansoura UniversityRan2020 to 2022Enrolled200ConditionsGenetic Predisposition to Disease
NCT04412486 early_phase1completednot on this map

An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19

TypeinterventionalSponsorGailen D. Marshall Jr., MD PhDRan2020 to 2023Enrolled86ConditionsCOVID-19ArmsCOVID Convalescent Plasma
3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. COVID-19 After Lung Resection in Northern Italy.Seminars in thoracic and cardiovascular surgery · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Zhou XuDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Shu LiDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Shen TianDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Hao LiDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Ling-Quan KongDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: huihuikp@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCoronavirus InfectionsBetacoronavirusChinaCOVID-19HumansPneumonia, ViralSARS-CoV-2

Identifiers

PMID32066525
PMCPMC7133601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.